
HealthMore in Health→
National Cancer Institute Launches Ivermectin Cancer Study Under RFK Jr.'s NIH, Alarming Scientists
Key Takeaways
- The National Cancer Institute launches a preclinical ivermectin cancer study under Trump-appointed NCI Director Anthony Letai
- Scientists are alarmed because no credible evidence supports ivermectin as an oncological treatment in humans
- The study was announced at a MAHA Institute event featuring NIH Director Jay Bhattacharya, raising politicization concerns
DE
DT Editorial Team··4 min read·via arstechnica.com



